Latest Press Releases

KFSHRC Inaugurates MENA’s Most Advanced Hematology Diagnostics Laboratory

RIYADH, Saudia Arabia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) inaugurated the Advanced Hematology Diagnostics Laboratory under the patronage of Deputy CEO Dr. Björn Zoéga. The ...

Mitolyn Reviews (Purple Peel Exploit For Weight Loss) Satisfied Customer Results or Fake Hype?

Mitolyn is a natural dietary supplement designed to support individuals struggling with stubborn body fat. It contains natural ingredients that address the root cause of weight gain and accelerate the metabolism to support fat burning. The ...

Pruitt & Earp Dentistry Expands Services and Commitment to Quality Care in Greenville, NC

When it comes to maintaining good oral health, choosing the right dental practice is essential. If you're looking for a dentist in Greenville, NC , look no further than Pruitt & Earp Dentistry . With two convenient locations in ...

The Wistar Institute Receives Two Biomedical Research Grants from the V Foundation for Cancer Research

PHILADELPHIA, PA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute assistant professors Nan Zhang, Ph.D. , and Noam Auslander Ph.D. , have both received independent funding totaling $1.2 million over the next three years for cancer ...

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (Brains Bio), a global leader in natural, GMP-compliant cannabinoid Active Pharmaceutical Ingredients (APIs), announces the expansion of its ...

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

PR Newswire INCHEON, South Korea, Dec. 18, 2024 - Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development - Investment highlights ...

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

PR Newswire CARLSBAD, Calif., Dec. 19, 2024 CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an ...

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PR Newswire LOS ANGELES, Dec. 18, 2024 LOS ANGELES, Dec. 18, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic ...

Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection

PR Newswire BERKELEY HEIGHTS, N.J., Dec. 18, 2024 BERKELEY HEIGHTS, N.J., Dec. 18, 2024 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals ...

Syrian American Medical Society (SAMS) Reaffirms Commitment to Syria's Health Crisis Amid Continued Power Transition

PR Newswire WASHINGTON, Dec. 18, 2024 Volunteer Doctors Introduce Health Assessment Report, Outlining Urgent Medical Solutions for Syria WASHINGTON, Dec. 18, 2024 /PRNewswire/ -- The Syrian American Medical Society (SAMS), global leader ...

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases

PR Newswire SCOTTSDALE, Ariz., Dec. 18, 2024 Findings from retrospective chart review of patients with suspected Parkinson's disease and related disorders show the use of skin biopsy for detection of abnormal synuclein in cutaneous nerves ...

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

PR Newswire DETROIT, Dec. 18, 2024 Karmanos is the first in the world with access to this innovative treatment that uses radiofrequencies to target and shrink cancerous tumors DETROIT, Dec. 18, 2024 /PRNewswire/ -- The Barbara Ann ...

MHA Issues New Report on Social Media and Youth Mental Health

PR Newswire ALEXANDRIA, Va., Dec. 18, 2024 Co-authored by young leaders, "Breaking the Algorithm" outlines recommendations to promote healthier experiences across digital platforms ALEXANDRIA, Va., Dec. 18, 2024 /PRNewswire/ -- Mental ...

Immorta Bio Advances Lung Cancer Immunotherapy with Peer-Reviewed Animal Data on Senolytic Vaccine

PR Newswire MIAMI, Dec. 18, 2024 Breakthrough Study Highlights SenoVax™'s Potential to Transform Cancer Treatment MIAMI, Dec. 18, 2024 /PRNewswire/ -- Immorta Bio Inc., a leader in longevity-focused biotechnologies, has announced the ...

Therapeutic Drug Monitoring Market to Hit USD 3.44 Billion by 2029 with 8.4% CAGR | MarketsandMarkets™

PR Newswire DELRAY BEACH, Fla., Dec. 18, 2024 DELRAY BEACH, Fla., Dec. 18, 2024 /PRNewswire/ -- The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to USD ...

Lucia Health Guidelines Initiates Clinical Study Evaluating its Lucia Health Coach Generative AI Agent for Educating and Supporting Patients with Atrial Fibrillation

PR Newswire SAN DIEGO, Dec. 18, 2024 Pilot study testing innovative agent designed to provide guideline-concordant education believed to be the first clinical study to evaluate an AI Agent with actual AFib patients SAN DIEGO, Dec. ...

Abilita Therapeutics and Orion Announce Research Collaboration to Develop Next-Generation Antibody Therapeutics in the Areas of Oncology and Pain

PR Newswire SAN DIEGO, Dec. 18, 2024 SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation ("Orion") focused ...

North Pole Nightmare Before Christmas

PR Newswire NORTH POLE, Alaska, Dec. 18, 2024 Naughty Canine Eats Santa's Head NORTH POLE, Alaska, Dec. 18, 2024 /PRNewswire/ -- Puppies will find and eat anything, even at the North Pole. Few, however, make a direct assault on the big ...

American Skin Association (ASA) Renews Partnership with SPOTS, an Awarding-Winning Educational Program Promoting Skin Health Awareness

PR Newswire NEW YORK, Dec. 18, 2024 NEW YORK, Dec. 18, 2024 /PRNewswire/ -- American Skin Association (ASA) is pleased to announce its renewed partnership with the Sun Protection Outreach Teaching by Students (SPOTS) program. SPOTS is an ...

PsychPlus to Accelerate Nationwide Expansion of Revolutionary Mental Health Ecosystem Targeting 20 New Markets in 2025 and Reducing the National Suicide Rate

PR Newswire HOUSTON, Dec. 18, 2024 PsychPlus, a pioneering leader in mental health care with a vision to reduce the national suicide rate, is taking bold steps toward transforming the U.S. mental health landscape. The company, distinguished ...

MNA Nurses of Salem Hospital Reach Tentative Contract Agreement to Help Protect Patient Care Quality by Respecting and Investing in Nurses

PR Newswire SALEM, Mass., Dec. 18, 2024 The tentative agreement follows a powerful informational picket by nurses in October that pushed Mass General Brigham to stabilize the Salem RN workforce SALEM, Mass., Dec. 18, 2024 /PRNewswire/ -- ...

Free burgers through Christmas? How about Free Health Year-Round?

PR Newswire CHANHASSEN, Minn., Dec. 18, 2024 Life Time takes on fast food frenzy with free consumer app to support healthy living CHANHASSEN, Minn., Dec. 18, 2024 /PRNewswire/ -- Countering the latest fast-food frenzy of free giveaways ...

Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)

Canada NewsWire MISSISSAUGA, ON, Dec. 18, 2024 The agreement is a critical step in ensuring paediatric patients living with NF1 PN have public access to Koselugo, the only approved therapy in Canada for this rare disease MISSISSAUGA, ON, ...

Talkiatry and ERC Pathlight Expand In-Network Care Pathways for Eating, Mood, and Anxiety Disorders

PR Newswire NEW YORK and DENVER, Dec. 18, 2024 NEW YORK and DENVER, Dec. 18, 2024 /PRNewswire/ -- Talkiatry and Eating Recovery Center (ERC) and Pathlight Mood & Anxiety Centers (Pathlight) today announced a partnership that eliminates gaps ...

The Max Foundation (Max) and the International PNH Interest Group (IPIG) Announce Collaboration to Improve Care and Management for People Living with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Low-Resource Countries

PR Newswire SEATTLE, Dec. 18, 2024 SEATTLE, Dec. 18, 2024 /PRNewswire/ -- The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to ...

Gurudev Sri Sri Ravi Shankar to Give Keynote Address at United Nations World Meditation Day, Followed by Live Global Meditation

PR Newswire NEW YORK, Dec. 18, 2024 Millions will join "World Meditates with Gurudev" on December 21, 9:30 AM EST / 2:30 GMT / 8:00 IST NEW YORK, Dec. 18, 2024 /PRNewswire-PRWeb/ -- Global spiritual leader and humanitarian Gurudev Sri ...

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

PR Newswire HONG KONG, Dec. 18, 2024 HONG KONG, Dec. 18, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouraging efficacy results from its study in diet-induced obese (DIO) mice combining ASC47, a ...

Lighthouse Recovery Now Accepting Aetna Insurance for Addiction and Mental Health Treatment in Dallas, Texas

PR Newswire DALLAS, Dec. 18, 2024 DALLAS, Dec. 18, 2024 /PRNewswire/ -- Lighthouse Recovery, a premier drug and alcohol addiction treatment center in Dallas, Texas, is proud to announce that it now accepts Aetna insurance for addiction and ...

Encompass Health Announces Preliminary Plans to Build a 50-bed Inpatient Rehabilitation Hospital in Bangor

PR Newswire BIRMINGHAM, Ala. and BANGOR, Maine, Dec. 18, 2024 BIRMINGHAM, Ala. and BANGOR, Maine, Dec. 18, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient ...

Holiday Gifts That Help Build Speech and Language Skills in Young Children

PR Newswire ROCKVILLE, Md., Dec. 18, 2024 Children Develop Communication, Pre-Literacy, and Learning Skills Through Play, Says ASHA ROCKVILLE, Md., Dec. 18, 2024 /PRNewswire/ -- If you're looking for last-minute gift ideas for a young ...

The Safest Way to Integrate AI Into Your Health System

PR Newswire WOBURN, Mass., Dec. 18, 2024 WOBURN, Mass., Dec. 18, 2024 /PRNewswire/ -- Report by Parlance: 87% of healthcare leaders interested in AI have yet to implement it. The majority express a strong desire to explore its potential, ...

MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH

PR Newswire CAMBRIDGE, Mass., Dec. 18, 2024 CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive ...

Arthrosi Therapeutics Surpasses 50% Patient Enrollment in Pivotal Phase 3 REDUCE 2 Trial of AR882 in Patients with Gout, Including Those with Tophaceous Gout

PR Newswire SAN DIEGO, Dec. 18, 2024 — Company anticipates completion of patient enrollment in 1H 2025 — SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially ...

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

PR Newswire BOSTON, Dec. 18, 2024 Approval given after Safety Review Committee (SRC) review of safety data from the three patients comprising Cohort 2 BOSTON, Dec. 18, 2024 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the ...

Children's Hospital Colorado Research Transforms the Standard of Care for Childhood Cancer

PR Newswire AURORA, Colo., Dec. 18, 2024 New FDA-approved drug greatly improves survival for children diagnosed with the most common form of childhood cancer AURORA, Colo. , Dec. 18, 2024 /PRNewswire/ -- After participating in a global ...

Latest Press Releases

Premium Press Releases »

KFSHRC Inaugurates MENA’s Most Advanced Hematology Diagnostics Laboratory

Mitolyn Reviews (Purple Peel Exploit For Weight Loss) Satisfied Customer Results or Fake Hype?

Pruitt & Earp Dentistry Expands Services and Commitment to Quality Care in Greenville, NC

The Wistar Institute Receives Two Biomedical Research Grants from the V Foundation for Cancer Research

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

Press Releases »

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection

Syrian American Medical Society (SAMS) Reaffirms Commitment to Syria's Health Crisis Amid Continued Power Transition

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

MHA Issues New Report on Social Media and Youth Mental Health

Immorta Bio Advances Lung Cancer Immunotherapy with Peer-Reviewed Animal Data on Senolytic Vaccine

Therapeutic Drug Monitoring Market to Hit USD 3.44 Billion by 2029 with 8.4% CAGR | MarketsandMarkets™

Lucia Health Guidelines Initiates Clinical Study Evaluating its Lucia Health Coach Generative AI Agent for Educating and Supporting Patients with Atrial Fibrillation

Abilita Therapeutics and Orion Announce Research Collaboration to Develop Next-Generation Antibody Therapeutics in the Areas of Oncology and Pain

North Pole Nightmare Before Christmas

American Skin Association (ASA) Renews Partnership with SPOTS, an Awarding-Winning Educational Program Promoting Skin Health Awareness

PsychPlus to Accelerate Nationwide Expansion of Revolutionary Mental Health Ecosystem Targeting 20 New Markets in 2025 and Reducing the National Suicide Rate

MNA Nurses of Salem Hospital Reach Tentative Contract Agreement to Help Protect Patient Care Quality by Respecting and Investing in Nurses

Free burgers through Christmas? How about Free Health Year-Round?

Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)

Talkiatry and ERC Pathlight Expand In-Network Care Pathways for Eating, Mood, and Anxiety Disorders

The Max Foundation (Max) and the International PNH Interest Group (IPIG) Announce Collaboration to Improve Care and Management for People Living with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Low-Resource Countries

Gurudev Sri Sri Ravi Shankar to Give Keynote Address at United Nations World Meditation Day, Followed by Live Global Meditation

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

Lighthouse Recovery Now Accepting Aetna Insurance for Addiction and Mental Health Treatment in Dallas, Texas

Encompass Health Announces Preliminary Plans to Build a 50-bed Inpatient Rehabilitation Hospital in Bangor

Holiday Gifts That Help Build Speech and Language Skills in Young Children

The Safest Way to Integrate AI Into Your Health System

MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH

Arthrosi Therapeutics Surpasses 50% Patient Enrollment in Pivotal Phase 3 REDUCE 2 Trial of AR882 in Patients with Gout, Including Those with Tophaceous Gout

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

Children's Hospital Colorado Research Transforms the Standard of Care for Childhood Cancer

Medindia Newsletters